Evaluation of the Effects of Two Dietary Supplement Formulations on the Lipid Profile in Mild Hypercholesterolemia

NARecruitingINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

December 17, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Hypercholesterolemia and HyperlipidemiaSupplementation
Interventions
DIETARY_SUPPLEMENT

Test Product A

Innovative formulation of a dietary supplement for mild hypercholesterolemia. Test Product A will be admistered daily for 8 weeks. After the fist 8 weeks, this arm will continue with the intake of the Product Test A for other 8 weeks.

DIETARY_SUPPLEMENT

Test Product B

Classic formulation of a dietary supplement for mild hypercholesterolemia. After the fist 8 weeks, this arm will continue with the intake of the Product Test A for other 8 weeks.

DIETARY_SUPPLEMENT

Placebo

"Placebo does not contain functional components and is indistinguishable from Product Test B.~After the fist 8 weeks, this arm will continue with the intake of the Product Test A for other 8 weeks."

Trial Locations (1)

40138

RECRUITING

S. Orsola-Malpighi University Hospital, Bologna

All Listed Sponsors
collaborator

Informapro Srl

OTHER

lead

IBSA Farmaceutici Italia Srl

INDUSTRY